BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 20624952)

  • 1. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS.
    Ling SC; Albuquerque CP; Han JS; Lagier-Tourenne C; Tokunaga S; Zhou H; Cleveland DW
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13318-23. PubMed ID: 20624952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.
    Kim SH; Shanware NP; Bowler MJ; Tibbetts RS
    J Biol Chem; 2010 Oct; 285(44):34097-105. PubMed ID: 20720006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond.
    Da Cruz S; Cleveland DW
    Curr Opin Neurobiol; 2011 Dec; 21(6):904-19. PubMed ID: 21813273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
    Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
    Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ; Volkening K
    FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43.
    Lanson NA; Maltare A; King H; Smith R; Kim JH; Taylor JP; Lloyd TE; Pandey UB
    Hum Mol Genet; 2011 Jul; 20(13):2510-23. PubMed ID: 21487023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
    Wang XN; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43/FUS in motor neuron disease: Complexity and challenges.
    Guerrero EN; Wang H; Mitra J; Hegde PM; Stowell SE; Liachko NF; Kraemer BC; Garruto RM; Rao KS; Hegde ML
    Prog Neurobiol; 2016; 145-146():78-97. PubMed ID: 27693252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
    Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
    PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 and FUS en route from the nucleus to the cytoplasm.
    Ederle H; Dormann D
    FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.
    Sun S; Ling SC; Qiu J; Albuquerque CP; Zhou Y; Tokunaga S; Li H; Qiu H; Bui A; Yeo GW; Huang EJ; Eggan K; Zhou H; Fu XD; Lagier-Tourenne C; Cleveland DW
    Nat Commun; 2015 Jan; 6():6171. PubMed ID: 25625564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rethinking ALS: the FUS about TDP-43.
    Lagier-Tourenne C; Cleveland DW
    Cell; 2009 Mar; 136(6):1001-4. PubMed ID: 19303844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein.
    Yang S; Warraich ST; Nicholson GA; Blair IP
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1408-11. PubMed ID: 20541619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
    Fiesel FC; Kahle PJ
    FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.